SCHEMBL1907680

SCHEMBL1907680

O=C1/C(=C\c2ccc(-c3cccc(Cl)c3)o2)SC(=S)N1CCS(=O)(=O)O

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DUSP3 P51452 1/20 1.00
MAP3K5 Q99683 7/20 0.77
MAPT P10636 2/20 0.73
HIF1AN Q9NWT6 1/20 0.59
MEN1 O00255 3/20 0.59
KMT2A Q03164 3/20 0.59
POLB P06746 2/20 0.59
PLA2G1B P04054 1/20 0.59
BLM P54132 1/20 0.59
GFER P55789 1/20 0.59
ATG4B Q9Y4P1 1/20 0.59
APEX1 P27695 1/20 0.58
MCL1 Q07820 2/20 0.56
TDP1 Q9NUW8 2/20 0.56
PKM P14618 1/20 0.56
EIF4E P06730 1/20 0.54
EIF4G1 Q04637 1/20 0.54
ALDH1A1 P00352 1/20 0.54
THRB P10828 1/20 0.54
RECQL P46063 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1907678 1.00 DUSP3 (1.00) DUSP3MAP3K5MAPTHIF1ANMEN1
SCHEMBL1907681 1.00 DUSP3 (1.00) DUSP3MAP3K5MAPTHIF1ANMEN1
SCHEMBL1905191 0.89 DUSP3 (0.81) DUSP3MAP3K5MAPTHIF1ANMEN1
SCHEMBL1905192 0.89 DUSP3 (0.81) DUSP3MAP3K5MAPTHIF1ANMEN1
SCHEMBL1905190 0.89 DUSP3 (0.81) DUSP3MAP3K5MAPTHIF1ANMEN1
SCHEMBL1901898 0.89 DUSP3 (0.80) DUSP3MAP3K5MAPTHIF1ANMEN1
SCHEMBL1901896 0.89 DUSP3 (0.80) DUSP3MAP3K5MAPTHIF1ANMEN1
SCHEMBL1901897 0.89 DUSP3 (0.80) DUSP3MAP3K5MAPTHIF1ANMEN1
SCHEMBL3893490 0.87 MAP3K5 (1.00) DUSP3MAP3K5MAPTHIF1ANMEN1
SCHEMBL6720214 0.87 MAP3K5 (1.00) DUSP3MAP3K5MAPTHIF1ANMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7947717-B2 Inhibitors of lethal factor protease BURNHAM INSTITUTE FOR MEDICAL RESEARCH (US) 2011-05-24 US disclosed
US-20100016292-A1 INHIBITORS OF LETHAL FACTOR PROTEASE THE BURNHAM INSTITUTE (US) 2010-01-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100016292-A1 INHIBITORS OF LETHAL FACTOR PROTEASE APAF1, F11, SERPINB1 DUSP3 2075/4885MAP3K5 2663/4885MAPT 2957/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.